| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |